Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer

Hardy-Werbin, M., Rocha, P., Arpi, O. et al. (13 more authors) (2019) Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. OncoImmunology. ISSN 2162-4011

Abstract

Metadata

Authors/Creators:
  • Hardy-Werbin, M.
  • Rocha, P.
  • Arpi, O.
  • Taus, Á.
  • Nonell, L.
  • Durán, X.
  • Villanueva, X.
  • Joseph-Pietras, D.
  • Nolan, L.
  • Danson, S. https://orcid.org/0000-0002-3593-2890
  • Griffiths, R.
  • Lopez-Botet, M.
  • Rovira, A.
  • Albanell, J.
  • Ottensmeier, C.
  • Arriola, E.
Copyright, Publisher and Additional Information: © 2019 Taylor & Francis Group, LLC. This is an author-produced version of a paper subsequently published in OncoImmunology. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: small cell lung cancer; ipilimumab; cytokines; immunotherapy; biomarkers
Dates:
  • Accepted: 28 February 2019
  • Published (online): 27 March 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 15 Apr 2019 14:11
Last Modified: 01 May 2019 10:40
Status: Published online
Publisher: Taylor & Francis
Refereed: Yes
Identification Number: https://doi.org/10.1080/2162402x.2019.1593810

Download

Accepted Version


Embargoed until: 27 March 2020

Filename: Manuscript.pdf

Request a copy

Share / Export

Statistics